HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of lectin pathway activity and mannan-binding lectin levels in the course of pregnancy complicated by diabetes type 1, based on the genetic background.

AbstractINTRODUCTION:
There are numerous indications that either mannan-binding lectin (MBL) deficiency or its excessive activity are associated with adverse pregnancy outcomes. High MBL concentrations and corresponding MBL2 genotypes were shown to be associated with microvascular complications in type 1 diabetes. The aim of this study was to evaluate levels of MBL and MBL-dependent activity of the lectin pathway (LP) of complement in the course of pregnancy in diabetic mothers, based on genetic background.
MATERIALS AND METHODS:
These parameters were determined in samples from healthy non-pregnant (control), diabetic non-pregnant, healthy pregnant, and pregnant diabetic women.
RESULTS:
No significant differences in median MBL levels or LP activities were found in any study group compared to the control. However, statistically significant differences in MBL levels were noted during pregnancy between the 1st and 3rd trimesters in both healthy controls and pregnant diabetics. With regard to LP values, similar trends were evident, but statistically significant results were obtained only in the healthy pregnant group. When data analysis was confined to patients carrying the A/A (wild-type) MBL2 genotype, an increase in MBL level during pregnancy (in both healthy and diabetic pregnant women) was still observed. Similarly, LP activity increased during both healthy and diabetic pregnancies, significantly so for the former.
CONCLUSIONS:
Diabetes, an autoimmune disease, is a serious complication of pregnancy. Therefore, determination of MBL status might be beneficial in identifying type 1 diabetic patients who are at increased risk of developing both vascular complications and poor pregnancy outcomes.
AuthorsMagdalena Pertyńska Marczewska, Maciej Cedzyński, Anna Swierzko, Agnieszka Szala, Małgorzata Sobczak, Katarzyna Cypryk, Jan Wilczyński
JournalArchivum immunologiae et therapiae experimentalis (Arch Immunol Ther Exp (Warsz)) 2009 May-Jun Vol. 57 Issue 3 Pg. 221-8 ISSN: 1661-4917 [Electronic] Switzerland
PMID19517215 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Glycated Hemoglobin A
  • MBL2 protein, human
  • Mannose-Binding Lectin
  • Complement System Proteins
Topics
  • Adult
  • Complement Pathway, Mannose-Binding Lectin (genetics, immunology)
  • Complement System Proteins (immunology, metabolism)
  • Diabetes Mellitus, Type 1 (blood, diagnosis, genetics)
  • Female
  • Genetic Predisposition to Disease
  • Glycated Hemoglobin (analysis)
  • Humans
  • Mannose-Binding Lectin (blood, genetics)
  • Pregnancy
  • Pregnancy Complications, Hematologic (blood, genetics, immunology)
  • Pregnancy Outcome (genetics)
  • Pregnancy in Diabetics (blood, genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: